You are here: Industry Insights > Moderna

News List

COVID-19 vaccines to enter late-stage trial by end of July: US’s top infectious diseases expert expresspharma
July 03, 2020
The news comes as Moderna, which is at the forefront of the country’s vaccine development efforts, reiterated earlier in the day that a late-stage trial with 30,000 volunteers would begin this month.
Moderna and Catalent announce collaboration for COVID-19 vaccine candidate expresspharma
June 28, 2020
Catalent to provide vial filling and packaging capacity, as well as additional staffing to support the production of an initial 100 million doses of the vaccine candidate from its facility in Bloomington, Indiana in the US.
Moderna COVID-19 vaccine appears to clear safety hurdle in mouse study expresspharma
June 16, 2020
Prior studies on a vaccine for SARS - a close cousin to the new virus that causes COVID-19 - suggests vaccines against this type of virus might have the unintended effect of causing more severe disease when the vaccinated person is later exposed to the ..
Lonza sets new goal to make Moderna COVID-19 vaccine ingredients expresspharma
June 04, 2020
Moderna, which enlisted Lonza in May in a 10-year manufacturing contract, is racing with 100-plus other vaccine projects, having last week dosed initial participants in a 600-patient study.
CordenPharma & Moderna Extend Manufacturing Agreement contractpharma
June 01, 2020
For the supply of lipid excipients to be used in Moderna's coronavirus vaccine.
Moderna’s Phase I Interim Data of mRNA-1273 Shows Promise contractpharma
May 27, 2020
Dose dependent increases in immunogenicity against SARS-CoV-2 were seen across the three dose levels.
Moderna’s Covid-19 vaccine shows significant effect in early human trial pharmaceutical-business-review
May 21, 2020
Moderna announced that its mRNA-1273 vaccine candidate against novel coronavirus (SARS-CoV-2) has demonstrated a significant effect in an early human trial.
Early data on Moderna’s COVID-19 vaccine insufficient: Stat News expresspharma
May 21, 2020
Moderna said the vaccine candidate, the first to be tested in the United States, produced protective antibodies in a small group of healthy volunteers.
Moderna gets FDA fast track status for mRNA vaccine against novel coronavirus pharmaceutical-business-review.
May 14, 2020
Moderna has secured fast track designation from the US Food and Drug Administration (FDA) for its mRNA-1273, the mRNA vaccine candidate against the novel coronavirus (SARS-CoV-2).
FDA fast-tracks Moderna’s Covid-19 vaccine candidate pharmaceutical-technology
May 14, 2020
The US Food and Drug Administration (FDA) has awarded fast-track designation to Moderna mRNA vaccine candidate, mRNA-1273, developed to protect against Covid-19.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 22 23 Next page